The pathophysiology of Parkinson's disease (PD) tremor remains incompletely understood
and there is a lack of clinical trials specifically addressing its pharmacological treatment …

Accelerometric tremorgrams were recorded from 25 subjects affected by essential tremor
and analysed by a Berg‐Fourier frequency analyser before and during venous infusion of …

Background and purpose Rest tremor is the most frequent sign of Parkinson's disease (PD)
after bradykinesia, occurring with various severity in about 75% of patients. An objective …

Previous studies have reported the resting tremor (RT) of Parkinson's disease to occur at
frequencies between 3–7 Hz and to be characterised by an alternating pattern of …

It is a matter of debate whether beta-blockers or primidone have a better influence on
essential tremor. It is also controversial whether essential tremor with synchronous …

Despite a large number of studies demonstrating the effectiveness of propranolol in relieving
essential tremor (ET) the long‐term therapeutic outcome of these patients remains poorly …

Since the first description of the disorder which we now call “Parkinson's Disease”(PD) much
has changed not only because of new therapeutic possibilities. Initially only the rest tremor …

Preliminary Evaluation of the Effects of Clonazepam on Parkinsonian Tremor Page 1 Eur.
Neurol. 15: 143-145 (1977) Preliminary Evaluation of the Effects of Clonazepam on …

The assessment of Parkinson's disease (PD) progression is essentially clinical and typically
based on performing neurological examinations and motor tests [1]; particularly, the current …

Objective: Assessment of the very long-acting dopamine agonist medication cabergoline in
the control of motor fluctuations in Parkinson's disease. Design: Open-label trial (13 weeks) …